Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M N Marra

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1996
Induction of interleukin-1 and interleukin-1 receptor antagonist during contaminated in-vitro dialysis with whole bloodR Schindler, S Krautzig, V Lufft, et al.
Blood Purification|January 1, 1993
Regulation of the response to bacterial lipopolysaccharide by endogenous and exogenous lipopolysaccharide binding proteinsM N Marra, M B Thornton, J L Snable, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1995
Activity of lipopolysaccharide-binding protein-bactericidal/permeability-increasing protein fusion peptide in an experimental model of Pseudomonas sepsisS M Opal, J E Palardy, J W Jhung, et al.
The Journal of Clinical Investigation|April 1, 1995
Protection against endotoxic shock by bactericidal/permeability-increasing protein in ratsH Jin, R Yang, S Marsters, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1989
Antibiotic proteins of human polymorphonuclear leukocytesJ E Gabay, R W Scott, D Campanelli, et al.
Critical Care Medicine|January 1, 1997
A comparison of bactericidal/permeability-increasing protein variant versus recombinant endotoxin-neutralizing protein for the treatment of Escherichia coli sepsis in rats A M Stack, R A Saladino, G R Siber, et al.
Annals of Surgery|July 1, 1994
Anti-endotoxin therapy in primate bacteremia with HA-1A and BPIM A Rogy, L L Moldawer, H S Oldenburg, et al.
Blood|August 15, 1990
The ontogeny of a 57-Kd cationic antimicrobial protein of human polymorphonuclear leukocytes: localization to a novel granule populationH A Pereira, J K Spitznagel, E F Winton, et al.
Archives of Surgery (Chicago, Ill. : 1960)|February 1, 1994
Changes in polymorphonuclear leukocyte surface and plasma bactericidal/permeability-increasing protein and plasma lipopolysaccharide binding protein during endotoxemia or sepsisS E Calvano, W A Thompson, M N Marra, et al.
Journal of Clinical Immunology|March 1, 1994
The role of bactericidal/permeability-increasing protein in the treatment of primate bacteremia and septic shockM A Rogy, H S Oldenburg, S E Calvano, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1996
Induction of interleukin-1 and interleukin-1 receptor antagonist during contaminated in-vitro dialysis with whole bloodR Schindler, S Krautzig, V Lufft, et al.
Blood Purification|January 1, 1993
Regulation of the response to bacterial lipopolysaccharide by endogenous and exogenous lipopolysaccharide binding proteinsM N Marra, M B Thornton, J L Snable, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1995
Activity of lipopolysaccharide-binding protein-bactericidal/permeability-increasing protein fusion peptide in an experimental model of Pseudomonas sepsisS M Opal, J E Palardy, J W Jhung, et al.
The Journal of Clinical Investigation|April 1, 1995
Protection against endotoxic shock by bactericidal/permeability-increasing protein in ratsH Jin, R Yang, S Marsters, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1989
Antibiotic proteins of human polymorphonuclear leukocytesJ E Gabay, R W Scott, D Campanelli, et al.
Critical Care Medicine|January 1, 1997
A comparison of bactericidal/permeability-increasing protein variant versus recombinant endotoxin-neutralizing protein for the treatment of Escherichia coli sepsis in rats A M Stack, R A Saladino, G R Siber, et al.
Annals of Surgery|July 1, 1994
Anti-endotoxin therapy in primate bacteremia with HA-1A and BPIM A Rogy, L L Moldawer, H S Oldenburg, et al.
Blood|August 15, 1990
The ontogeny of a 57-Kd cationic antimicrobial protein of human polymorphonuclear leukocytes: localization to a novel granule populationH A Pereira, J K Spitznagel, E F Winton, et al.
Archives of Surgery (Chicago, Ill. : 1960)|February 1, 1994
Changes in polymorphonuclear leukocyte surface and plasma bactericidal/permeability-increasing protein and plasma lipopolysaccharide binding protein during endotoxemia or sepsisS E Calvano, W A Thompson, M N Marra, et al.
Journal of Clinical Immunology|March 1, 1994
The role of bactericidal/permeability-increasing protein in the treatment of primate bacteremia and septic shockM A Rogy, H S Oldenburg, S E Calvano, et al.
Pageof 2